These are smokers who could benefit from access to alternative products that can effectively deliver nicotine and provide a reduced-risk alternative*† to smoking. It is this group of people for whom effective Tobacco Harm Reduction policy matters most.
In the UK, Public Health England has published a series of expert reviews of the latest evidence, drawing on peer-reviewed literature, surveys and other reports, concluding: “based on current knowledge, vaping is at least 95% less harmful than smoking”2.
allowing robust science to lead to greater consumer choice, quality and confidence.
where science-based evidence and risk are understood and differentiated to guide regulatory policy.
to ensure products can evolve to meet changing consumer preferences.
to ensure regulators and consumers can make
that facilitate the acceleration of movement of consumers from combustible to non-combustible products.
Industry, government, scientists, regulators and governing bodies must come together in order to create effective Tobacco Harm Reduction policy that is based on evidence and supports the role alternatives can play for those who would otherwise continue to smoke. This is not something that can be tackled by one group alone.
Engagement, dialogue and communication among all parties is what is required in the development of effective policy. By adopting a more inclusive stakeholder approach to Tobacco Harm Reduction, we hope that greater progress can be made and we can accelerate the switch away from smoking for the more than one billion people who smoke worldwide.
* Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
† Our products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.
1. Advancing our health: prevention in the 2020s – consultation document. July 2019. Parliamentary Under Secretary of State for Public Health and Primary Care - VIEW LINK
2. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Vaping in England: an evidence update including mental health and pregnancy, March 2020: a report commissioned by Public Health England. London: Public Health England, 2020